Kiniksa Pharmaceuticals International, plc
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $677.6 | $423.2 | $270.3 | $220.2 | $38.5 |
| Operating income | $77.2 | -$45.6 | -$25.2 | $9.8 | -$156.6 |
| Net income | $59.0 | -$43.2 | $14.1 | $183.4 | -$157.9 |
| Cash Flow Statement | |||||
| Free cash flow | $136.4 | $25.4 | $13.2 | $5.7 | -$126.7 |
Shares outstanding 78.0M · Free float 41.9%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.